Report Type: Therapy Reports
Report Category: Women's Health
Report Subcategory: Dysmenorrhea
Price: 2999.00
Date: January 2022

Dysmenorrhea: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Dysmenorrhea
Dysmenorrhea is the condition of painful menstrual periods which are caused by uterine contractions. Primary dysmenorrhea refers to recurrent pain, while secondary dysmenorrhea results from reproductive system disorders.

Top 10 Companies:
Johnson & Johnson
Pfizer Inc
Bayer AG
Novartis AG
GlaxoSmithKline Plc
Sanofi
Abbott Laboratories
Bristol-Myers Squibb Co
AstraZeneca Plc
Teva Pharmaceutical Industries Ltd